Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne M Crowe

Showing results (111-120 of 141) with videos related to

Pageof 15
Sort By:
Journal of the International AIDS Society|March 7, 2018
A tale of two countries: progress towards UNAIDS 90-90-90 targets in Botswana and AustraliaTafireyi Marukutira, Mark Stoové, Shahin Lockman, et al.
Journal of Medical Microbiology|November 24, 2007
Use of an HIV-1 reverse-transcriptase enzyme-activity assay to measure HIV-1 viral load as a potential alternative to nucleic acid-based assay for monitoring antiretroviral therapy in resource-limited settingsH Syed Iqbal, P Balakrishnan, Anitha J Cecelia, et al.
The Journal of International Medical Research|September 28, 2020
Performance characteristics of an instrument-free point-of-care CD4 test (VISITECT®CD4) for use in resource-limited settingsVairamohan Vidhyavathi, Hussain Syed Iqbal, Kannaiyan Kanthamani, et al.
Frontiers in Immunology|June 6, 2018
Polymorphism rs1385129 Within Glut1 Gene <i>SLC2A1</i> Is Linked to Poor CD4+ T Cell Recovery in Antiretroviral-Treated HIV+ IndividualsJesse J R Masson, Catherine L Cherry, Nicholas M Murphy, et al.
Journal of Clinical Microbiology|November 23, 2018
Field Performance and Diagnostic Accuracy of a Low-Cost Instrument-Free Point-of-Care CD4 Test (Visitect CD4) Performed by Different Health Worker Cadres among Pregnant WomenStanley Luchters, Karl Technau, Yasmin Mohamed, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 30, 2012
Virologically suppressed HIV patients show activation of NK cells and persistent innate immune activationGregor F Lichtfuss, Wan-Jung Cheng, Yagmur Farsakoglu, et al.
The Journal of Infectious Diseases|October 29, 2010
Both CD31(+) and CD31⁻ naive CD4(+) T cells are persistent HIV type 1-infected reservoirs in individuals receiving antiretroviral therapyFiona Wightman, Ajantha Solomon, Gabriela Khoury, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2007
The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivoPhilip J Ellery, Emma Tippett, Ya-Lin Chiu, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 1, 2019
People who inject drugs in Bangladesh - The untold burden!Sharful I Khan, Md Masud Reza, Suzanne M Crowe, et al.
AIDS (London, England)|January 8, 2015
Plasma interleukin-18 levels are a biomarker of innate immune responses that predict and characterize tuberculosis-associated immune reconstitution inflammatory syndromeHong Yien Tan, Yean Kong Yong, Bruno B Andrade, et al.
Pageof 15

Showing results (111-120 of 141) with videos related to

Sort By:
Pageof 15
Journal of the International AIDS Society|March 7, 2018
A tale of two countries: progress towards UNAIDS 90-90-90 targets in Botswana and AustraliaTafireyi Marukutira, Mark Stoové, Shahin Lockman, et al.
Journal of Medical Microbiology|November 24, 2007
Use of an HIV-1 reverse-transcriptase enzyme-activity assay to measure HIV-1 viral load as a potential alternative to nucleic acid-based assay for monitoring antiretroviral therapy in resource-limited settingsH Syed Iqbal, P Balakrishnan, Anitha J Cecelia, et al.
The Journal of International Medical Research|September 28, 2020
Performance characteristics of an instrument-free point-of-care CD4 test (VISITECT®CD4) for use in resource-limited settingsVairamohan Vidhyavathi, Hussain Syed Iqbal, Kannaiyan Kanthamani, et al.
Frontiers in Immunology|June 6, 2018
Polymorphism rs1385129 Within Glut1 Gene <i>SLC2A1</i> Is Linked to Poor CD4+ T Cell Recovery in Antiretroviral-Treated HIV+ IndividualsJesse J R Masson, Catherine L Cherry, Nicholas M Murphy, et al.
Journal of Clinical Microbiology|November 23, 2018
Field Performance and Diagnostic Accuracy of a Low-Cost Instrument-Free Point-of-Care CD4 Test (Visitect CD4) Performed by Different Health Worker Cadres among Pregnant WomenStanley Luchters, Karl Technau, Yasmin Mohamed, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 30, 2012
Virologically suppressed HIV patients show activation of NK cells and persistent innate immune activationGregor F Lichtfuss, Wan-Jung Cheng, Yagmur Farsakoglu, et al.
The Journal of Infectious Diseases|October 29, 2010
Both CD31(+) and CD31⁻ naive CD4(+) T cells are persistent HIV type 1-infected reservoirs in individuals receiving antiretroviral therapyFiona Wightman, Ajantha Solomon, Gabriela Khoury, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2007
The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivoPhilip J Ellery, Emma Tippett, Ya-Lin Chiu, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 1, 2019
People who inject drugs in Bangladesh - The untold burden!Sharful I Khan, Md Masud Reza, Suzanne M Crowe, et al.
AIDS (London, England)|January 8, 2015
Plasma interleukin-18 levels are a biomarker of innate immune responses that predict and characterize tuberculosis-associated immune reconstitution inflammatory syndromeHong Yien Tan, Yean Kong Yong, Bruno B Andrade, et al.
Pageof 15